Efficacy and safety of a novel hemostatic forceps in endoscopic submucosal dissection for gastric neoplasm: a prospective randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0008165
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 266
Inclusion Criteria
1. Diagnosed as adenoma or early gastric cancer and meets the indications for endoscopic resection
2. Where he/she voluntarily signed a written informed consent form after hearing an explanation of the purpose, method, effect, etc. of the study
Exclusion Criteria
1. Women of childbearing potential who are unable to use adequate contraception or are pregnant or lactating
2. Past history of gastrectomy
3. When endoscopic resection cannot be safely performed due to hemorrhagic disease or coagulation disorder
4. When the investigator determines that endoscopic resection is impossible
5. Who do not understand the purpose of the study or do not consent to the examination
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total time required to hemostasis for all bleeding events during endoscopic submucosal dissection (seconds) ;Abdominal pain, bleeding, or infection after the procedure
- Secondary Outcome Measures
Name Time Method Satisfaction of operators and assistants regarding hemostasis